Literature DB >> 16779736

Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.

D M Scollard1, M P Joyce, T P Gillis.   

Abstract

Humanized monoclonal antibodies to tumor necrosis factor- alpha are valuable for the treatment of rheumatologic conditions, but they have been associated with the development of serious infections. We report the first 2 cases of leprosy developing after treatment with infliximab. After discontinuation of infliximab, both patients developed type 1 ("reversal") leprosy reactions.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16779736     DOI： 10.1086/505222

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  32 in total

Review 1.  Case series in drug safety: a review to determine characteristics and quality.

Authors:  Claire Nour Abou Chakra; Antoine Pariente; Marion Pinet; Lenhangmbong Nkeng; Nicholas Moore; Yola Moride
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

Review 2.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 3.  Leprosy as a genetic disease.

Authors:  Andrea Alter; Audrey Grant; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Mamm Genome       Date:  2010-10-09       Impact factor: 2.957

Review 4.  Infectious complications associated with monoclonal antibodies and related small molecules.

Authors:  Edsel Maurice T Salvana; Robert A Salata
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 5.  Leprosy in the 21st century.

Authors:  Cassandra White; Carlos Franco-Paredes
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

6.  Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States.

Authors:  Sarah M Labuda; John S Schieffelin; Jeffrey G Shaffer; Barbara M Stryjewska
Journal:  Am J Trop Med Hyg       Date:  2017-10-19       Impact factor: 2.345

Review 7.  Immune reconstitution reactions in human immunodeficiency virus-negative patients: report of a case and review of the literature.

Authors:  Tiffany C Scharschmidt; Erin H Amerson; Oren S Rosenberg; Richard A Jacobs; Timothy H McCalmont; Kanade Shinkai
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

8.  Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.

Authors:  Martin Rottman; Emilie Catherinot; Patrick Hochedez; Jean-François Emile; Jean-Laurent Casanova; Jean-Louis Gaillard; Claire Soudais
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Biologics in Leprosy: A Systematic Review and Case Report.

Authors:  Anna L Cogen; Eglantine Lebas; Barbara De Barros; James P Harnisch; William R Faber; Diana N Lockwood; Stephen L Walker
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

10.  Two patients with leprosy and the sudden appearance of inflammation in the skin and new sensory loss.

Authors:  Carlos Franco-Paredes; Jesse T Jacob; Barbara Stryjewska; Leo Yoder
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.